cognitive cybersecurity intelligence

News and Analysis

Beyond Biotech podcast 61 – Blood Cancer Awareness Month

In recognition of Blood Cancer Awareness Month, Affimed’s CMO, Andreas Harstrick, discusses the firm’s methods for tackling blood cancers. Affimed focuses on harnessing the innate immune system, which is usually overlooked, and resulted in a 71% complete response rate in an exploratory study.  The firm uses “natural killer” cells, part of our first line of immune defense.

Source: –

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts